To carry out the study, retrospective clinical data was collected by researchers from clinicians and caretakers of 10 children with drug-resistant epilepsy. The researchers ensured that the 10 patients recruited for the research had not responded to any CBD products. The children recruited were of the average age of six but ranged between 1 to 13 years. These kids had a range of epilepsies and various kinds of co-existing issues like learning abilities, global developmental delay, and infantile spasms.
Members of Outlawz have said for years that they mixed some of Tupac Shakur’s ashes…
State and local police made at least 218,152 marijuana-related arrests in 2025, including 200,960 for…
Three days in Philadelphia, September 25 to 27, with a free record-clearing clinic and a…
Four decades after its Amsterdam beginnings, Barney’s Farm is marking the milestone with new markets,…
Gallup’s new numbers hold a small, awkward pattern: the Americans most convinced cannabis is bad…
The FDA is seeking outside data and analytics services to better understand how people use…